Cheng, Robert K. Y.
Fiez-Vandal, Cédric
Schlenker, Oliver
Edman, Karl
Aggeler, Birte
Brown, Dean G.
Brown, Giles A.
Cooke, Robert M.
Dumelin, Christoph E.
Doré, Andrew S.
Geschwindner, Stefan
Grebner, Christoph
Hermansson, Nils-Olov
Jazayeri, Ali
Johansson, Patrik
Leong, Louis
Prihandoko, Rudi
Rappas, Mathieu
Soutter, Holly
Snijder, Arjan
Sundström, Linda
Tehan, Benjamin
Thornton, Peter
Troast, Dawn
Wiggin, Giselle
Zhukov, Andrei
Marshall, Fiona H.
Dekker, Niek
Article History
Received: 3 August 2016
Accepted: 28 March 2017
First Online: 26 April 2017
Competing interests
: R.K.Y.C., C.F.-V., O.S., G.A.B., R.M.C., A.S.D., A.J., R.P., M.R., B.T., G.W., A.Z. and F.H.M. are employees of Heptares Therapeutics limited and are shareholders in Sosei Group Corporation. K.E., D.G.B., S.G., C.G., N.-O.H., P.J., A.S., L.S., P.T. and N.D. are employees and shareholders of AstraZeneca. B.A. and L.L. are employees and shareholders of Bio-techne. C.E.D., H.S. and D.T. are employees and shareholders of X-Chem Inc.